Stryker Corp (SYK)

Common Stock
Sell: $361.02|Buy: $388.00|Change: 2.70 (0.71%)

Open 

$379.57


Previous close 

$381.33


Trade high 

$386.564


Volume 

457


Year high 

$404.87


Year low 

$329.161


Dividend yield 

0.88%


Market capitalisation 

$146.96 bn


P/E ratio 

45.80


ISIN 

US8636671013


Share price

Dividends

PreviousLatest
Record date31/12/202531/03/2026
Ex-dividend date31/12/202531/03/2026
Payment date30/01/202630/04/2026
Amount$0.88$0.88

Performance 25/02/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Stryker Corp+ 0.71
More...

Company profile

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.